New Study Finds Low Overdiagnosis in Breast Cancer Screening

Women undergoing breast‑cancer screening are routinely told that the tests can sometimes identify tumors that would never have produced symptoms or health problems during their lives, a phenomenon described by health officials as overdiagnosis. The warning, included in informational leaflets and counseling sessions across many national screening programs, aims to help participants weigh the benefits of early detection against the possibility of unnecessary treatment.

Overdiagnosis occurs when screening discovers slow‑growing or non‑aggressive cancers that might remain dormant, leading to interventions such as surgery, radiation or chemotherapy that would not have been required. Studies estimate that a modest proportion of detected cases fall into this category, prompting ongoing research into risk‑adjusted screening protocols and more precise diagnostic tools. Health authorities continue to emphasize informed consent, ensuring women understand both the life‑saving potential of mammography and the risk of overtreatment before deciding to participate.